Frances Lynn

6.9k citations
19 papers · 4.7k indexed · 2 hit papers · h-index 13

Impact in

Papers in

Frances Lynn

19 papers receiving 4.5k citations

Hit Papers

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis 2006 · 2.4k citations
2.4k200620262012201950010001.5k2.0k

Peers

Frances Lynn
Comparison fields: 5 of 105
  • Pathology and Forensic Medicine 3.6k
  • Neurology 1.2k
  • Oncology 1.9k
  • Immunology 1.1k
  • Rheumatology 760
Replace A Wajgt with:
A Wajgt Poland
Omar Khan United States
Paolo A. Muraro United Kingdom
Daniel Wynn United States
Gavin Giovannoni United Kingdom
Martin Toal United States
Ludwig Kappos Switzerland
David Margolin United States
J. S. Wolinsky United States
Craig H. Smith United States
Frances Lynn relative to A Wajgt Poland A Wajgt's profile →
Citations per field
00.5×1.6×
A Wajgt · 1×
Citations per year

Countries citing papers authored by Frances Lynn

Since Specialization
Citations

This map shows the geographic impact of Frances Lynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances Lynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances Lynn more than expected).

Fields of papers citing papers by Frances Lynn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances Lynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances Lynn. The network helps show where Frances Lynn may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Frances Lynn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frances Lynn Line = papers co-authored together Frances Lynn links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 2013138
2 201153
3 201043
4 2009183
5 20092
6 200975
7 2009199
8 20099
9 20081
10 20075
11 2007236
12 20071
13 2007249
14
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
Hit paper breakdown →
2006982
15 200629
16
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Hit paper breakdown →
20062413
17
The effects of natalizumab on brain atrophy and cognitive function: results from the AFFIRM study
20061
18 198021
19 198022

About Frances Lynn

Frances Lynn is a scholar working on Pathology and Forensic Medicine, Oncology, Biological Psychiatry, Hematology and Immunology, having authored 19 papers that have together received 4.7k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (14 papers), Polyomavirus and related diseases (10 papers), Autoimmune and Inflammatory Disorders Research (3 papers), Immunotherapy and Immune Responses (2 papers), Lymphoma Diagnosis and Treatment (2 papers), T-cell and Retrovirus Studies (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (3.6k citations), Neurology (1.2k citations), Oncology (1.9k citations), Immunology (1.1k citations) and Rheumatology (760 citations). Frances Lynn has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Michael Panzara, Fred Lublin, Alfred Sandrock, Michael Hutchinson, Eva Havrdová, J. Theodore Phillips, A Wajgt, Paul O’Connor, Chris H. Polman and David H. Miller. Their work appears in journals such as Neurology, Journal of Neurology, New England Journal of Medicine, Journal of the Neurological Sciences and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026